Saint-Malo Cedex

France

40 total trials 25 recruiting

Filter these 40 trials by phase, condition, sponsor and more.

Open in Search →

THINK - intensification of blood pressure lowering Therapeutics based on diuretics versus usual management for uncontrolled Hypertension IN … Recruiting

2022-501494-39-00 5 2023-03-28 Uncontrolled Hypertension IN patients with moderate to severe chronic
Randomized phase 3 trial comparing FOLFOX to gemcitabine in metastatic first-line in patients with pancreatic adenocarcinoma and non-fit for … Recruiting

2024-511904-18-00 10 2020-07-08 Pancreatic adenocarcinoma (PAC)
PRODIGE 85 (FFCD 1804) – KANALRAD Prospective randomized phase III study evaluating induction chemotherapy (modified DCF 4 cycles) followed … Ended recruitment

2023-505972-32-00 5 2024-02-26 locally advanced anal squamous cell carcinoma
A Study to Evaluate ABP 206 Compared with OPDIVO® (Nivolumab) in Subjects with Unresectable or Metastatic Melanoma Ended recruitment

2023-503288-40-00 5 2024-01-26 Unresectable or Metastatic Melanoma
TRIO: A prospective randomized Trial of non-inferiority comparing RItuximab versus Ocrelizumab in relapsing-remitting multiple sclerosis. Ended recruitment

2022-501027-25-01 11 2023-06-01 Multiple Sclerosis
PRODIGE 81-FFCD 2101-TRIPLET: Study evaluating the benefit of adding Ipilimumab to the combination of Atezolizumab and Bevacizumab in patien … Ended recruitment

2022-501217-31-00 10 2023-03-09 Hepatocellular carcinoma
Reduction of hormone therapy duration in women with hormonesensitive breast cancer at very low risk of metastatic recurrence Ended recruitment

2024-514480-26-00 4 2022-10-12 Post-menopausal women with localized luminal A breast cancer and consi
MEthotrexate versus TOcilizumab for treatment of GIant cell Arteritis: a multicenter, randomized, controlled trial Ended recruitment

2024-512269-14-00 5 2020-01-27 GIant cell Arteritis
A Phase 3 Study Comparing Lenalidomide and Daratumumab Subcutaneous Injection (R-Dara SC) vs Lenalidomide and Dexamethasone (Rd) in Frail Su … Ended recruitment

2024-514088-25-00 5 2019-10-07 Multiple Myeloma
Maintaining or Stopping immunosuppressive Therapy in patients with ANCA vasculitis and End-stage Renal disease: a prospective, multicenter, … Ended recruitment

2024-512470-10-00 11 2018-02-02 End-stage Renal disease
IRinotecan and Oxaliplatin for Colon Cancer in Adjuvant Setting Ended recruitment

2024-517489-41-00 5 2017-03-27 High-risk stage III colon cancer
PAlbociclib and Circulating Tumor DNA for ESR1 Mutation Detection Ended recruitment

2024-510704-37-00 5 2017-03-22 ER+/HER2- metastatic breast cancer
PRODIGE 34 - ADAGE: Randomised phase III study evaluating adjuvant chemotherapy after resection of stage III colon adenocarcinoma in patient … Ended recruitment

2024-518741-21-00 4 2014-12-23 colon cancer
A global study of volrustomig (MEDI5752) plus chemotherapy versus pembrolizumab plus chemotherapy for participants with metastatic non-small … Halted

2023-503298-39-00 5 2024-06-13 Metastatic Non-Small Cell Lung Cancer (mNSCLC)
Perioperative Treatment in Resectable Gastric Cancer with Spartalizumab (PDR001) in Combination with fluorouracil, leucovorin, oxaliplatin, … Ended

2024-516299-13-00 4 2024-09-06 Resectable Gastric Cancer
PRODIGE 111 – DOMZIGAST A randomized phase II study evaluating FOLFIRI vs FOLFIRI plus Domvanalimab (anti-TIGIT) and Zimberelimab (anti-PD1) … Ended

2024-519258-35-00 4 stomach cancer

Showing 25–40 of 40 trials